New Secondary Antibodies Launched for Camelid Antibody Development
28 Jan 2019
David Fancy, Ph.D., Chief Operations Officer for Jackson Immuno Research announces the launch of new anti-camelid antibodies that are not just for the development of nanobodies from alpaca and llamas, but can also be used in downstream applications.
About the company
Jackson ImmunoResearch Laboratories Inc.
Jackson ImmunoResearch Laboratories, Inc. specializes in the production and conjugation of affinity-purified secondary antibodies and purified immunoglobulins. Its products are sold primarily to scientists in universities and research institutes throughout the world who are conducting research in the plant, animal, and biomedical sciences.
The company is located in rural Pennsylvania, near the Amish country, about 40 miles west of Philadelphia. It was started in 1982 by scientists whose education and previous experience included research in cell biology, protein chemistry, microbiology, and product development in immunology. The company’s goal is to provide other scientists with the newest, largest selection of, and highest quality of secondary reagents, with the best technical and customer services possible. The products are for research use only, and not for diagnostics or therapeutics. They are not primary antibodies, nor are they medical devices.
